Century Therapeutics, Inc. (IPSC) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $61.85M | +5.8% |
| 2024 | $58.44M | +23.5% |
| 2023 | $47.32M | -43.8% |
| 2022 | $84.27M | +49.3% |
| 2021 | $56.45M | +107.4% |
| 2020 | $27.21M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $61.85M | +5.8% |
| 2024 | $58.44M | +23.5% |
| 2023 | $47.32M | -43.8% |
| 2022 | $84.27M | +49.3% |
| 2021 | $56.45M | +107.4% |
| 2020 | $27.21M | — |